Livforsakringsbolaget Skandia Omsesidigt Sells 500 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Livforsakringsbolaget Skandia Omsesidigt decreased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 56.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 392 shares of the medical device company’s stock after selling 500 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Cooper Companies were worth $34,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of COO. Benjamin F. Edwards & Company Inc. raised its stake in Cooper Companies by 248.6% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after buying an additional 174 shares during the period. Covestor Ltd increased its stake in shares of Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after purchasing an additional 208 shares during the period. Global Retirement Partners LLC increased its stake in shares of Cooper Companies by 358.6% during the first quarter. Global Retirement Partners LLC now owns 321 shares of the medical device company’s stock worth $33,000 after purchasing an additional 251 shares during the period. Clearstead Trust LLC bought a new position in shares of Cooper Companies during the first quarter worth approximately $36,000. Finally, Byrne Asset Management LLC increased its stake in shares of Cooper Companies by 300.0% during the first quarter. Byrne Asset Management LLC now owns 360 shares of the medical device company’s stock worth $37,000 after purchasing an additional 270 shares during the period. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, May 31st. Piper Sandler restated an “overweight” rating and set a $115.00 price objective on shares of Cooper Companies in a research note on Wednesday, July 3rd. Robert W. Baird raised their price objective on Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Finally, Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $111.78.

Cooper Companies Price Performance

COO traded down $1.36 on Monday, reaching $91.77. The stock had a trading volume of 788,810 shares, compared to its average volume of 1,108,239. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $104.07. The firm has a 50-day moving average of $91.03 and a 200-day moving average of $94.06. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $18.27 billion, a price-to-earnings ratio of 54.27, a price-to-earnings-growth ratio of 2.34 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $942.60 million for the quarter, compared to analyst estimates of $948.07 million. During the same quarter in the previous year, the company posted $0.77 EPS. The business’s revenue was up 7.4% on a year-over-year basis. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.